B
Bishoy Rizkalla
Researcher at Baker IDI Heart and Diabetes Institute
Publications - 10
Citations - 1090
Bishoy Rizkalla is an academic researcher from Baker IDI Heart and Diabetes Institute. The author has contributed to research in topics: Vascular endothelial growth factor & Kidney. The author has an hindex of 5, co-authored 7 publications receiving 866 citations. Previous affiliations of Bishoy Rizkalla include University of Melbourne.
Papers
More filters
Journal ArticleDOI
Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.
Mark E. Cooper,Dimitria Vranes,Sherif Youssef,Steven A. Stacker,Alison J. Cox,Bishoy Rizkalla,David J. Casley,Leon A. Bach,Darren J. Kelly,Richard E. Gilbert +9 more
TL;DR: Assessment of VEGF, 125I-VEGF binding, and vascular endothelial growth factor receptor-2 (VEGFR-2) in the kidney was performed after 3 and 32 weeks of streptozotocin-induced diabetes to indicate an early and persistent increase in renal V EGF gene expression in association with experimental diabetes.
Journal ArticleDOI
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
You-yi Li,Xin Wang,Dianna M. Blau,Mauricio T. Caballero,Daniel R. Feikin,Christopher Hill,Shabir A. Madhi,Saad B. Omer,Eric A. F. Simões,Harry Campbell,Ana Pariente,Darmaa Bardach,Quique Bassat,Jean-Sébastien Casalegno,Giorgi Chakhunashvili,Nigel W Crawford,Daria Danilenko,Lien Anh Ha Do,Marcela Echavarria,Angela Gentile,Aubree Gordon,Terho Heikkinen,Q. Sue Huang,Sophie Jullien,Anand Krishnan,Eduardo López,Joško Markić,Ainara Mira-Iglesias,Hannah C. Moore,Jocelyn Moyes,Lawrence Mwananyanda,D. James Nokes,Faseeha Noordeen,Evangeline Obodai,Nandhini Palani,Candice Romero,Vahid Salimi,Ashish Satav,Eu Jin Seo,Zakhar Shchomak,Rosalyn J. Singleton,Kirill Stolyarov,Sonia K. Stoszek,Anne von Gottberg,Danielle F. Wurzel,Lay-Myint Yoshida,Chee Fu Yung,Heather J. Zar,Harish Nair,Michael E. Abram,Jeroen Aerssens,A. M. Alafaci,Angel Balmaseda,Teresa Bandeira,Ian G. Barr,Ena Batinović,Philippe Beutels,Jinal N. Bhiman,Christopher C Blyth,Louis Bont,Sara S Bressler,Cheryl Cohen,Rachel Cohen,Anna Maria G. Costa,Rowena Crow,Andrew J Daley,Duc Anh Dang,Clarisse Demont,Chris A. Desnoyers,Javier Díez-Domingo,Maduja V M Divarathna,Mignon du Plessis,Madeleine Edgoose,F. Martin Ferolla,Thea Kølsen Fischer,Amanuel Tesfay Gebremedhin,Carlo Giaquinto,Yves Gillet,Roger Hernandez,C Horvat,Etienne Javouhey,Irakli Karseladze,John Kubale,Rakesh Kumar,Bruno Lina,Florencia Lución,Rae Macginty,Federico Martinón-Torres,Alissa McMinn,Adam Meijer,Petra Milić,Adrian Morel,Kim Mulholland,Tuya Mungun,Nickson Murunga,Claire Newbern,Mark P. Nicol,John Kofi Odoom,Peter J. M. Openshaw,Dominique Ploin,Fernando P. Polack,Andrew J. Pollard,Namrata Prasad,Joan Puig-Barberà,Janine Reiche,Noelia Reyes,Bishoy Rizkalla,Shilpa Satao,Ting Shi,Sujatha Sistla,Matthew D. Snape,Yanran Song,Giselle Soto,Forough Tavakoli,Michiko Toizumi,Naranzul Tsedenbal,Maarten van den Berge,Charlotte Vernhes,Claire von Mollendorf,Sibongile Walaza,Gregory J. Walker +120 more
TL;DR: This systematic analysis aims to update RSV-associated acute lower respiratory infection morbidity and mortality at global, regional, and national levels in children aged 0–60 months for 2019, with focus on overall mortality and narrower infant age groups that are targeted by RSV prophylactics in development.
Journal ArticleDOI
Attenuation of Extracellular Matrix Accumulation in Diabetic Nephropathy by the Advanced Glycation End Product Cross-Link Breaker ALT-711 via a Protein Kinase C-α−Dependent Pathway
Vicki Thallas-Bonke,Carsten Lindschau,Bishoy Rizkalla,Leon A. Bach,Geoffrey Boner,Matthias Meier,Hermann Haller,Mark E. Cooper,Josephine M. Forbes +8 more
TL;DR: Findings implicate AGEs as important stimuli for the activation of PKC, particularly PKC-alpha, in the diabetic kidney, which can be directly inhibited by ALT-711.
Journal ArticleDOI
Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin
Stella Sarlos,Bishoy Rizkalla,Christina J. Moravski,Zemin Cao,Mark E. Cooper,Jennifer L. Wilkinson-Berka +5 more
TL;DR: A potential retinoprotective role for AT2-RB possibly mediated via interactions with VEGF- and angiopoietin-dependent pathways is identified.
Journal ArticleDOI
Increased Renal Vascular Endothelial Growth Factor and Angiopoietins by Angiotensin II Infusion Is Mediated by Both AT1 and AT2 Receptors
TL;DR: Findings extend the increasing evidence that the AT(2) receptor, in addition to the At(1) receptor subtype, plays an important role in mediating the proliferative actions of angiotensin II in the kidney.